It is a pharma private limited company based in Milk Cly Mumbai, Maharashtra, India, established in 2018.
2018 | Milk Cly Mumbai, Maharashtra, India | ActiveRevigro Pharmaceutical Private Limited, a active private limited company, was established on 21 August 2018 in Milk Cly Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24111MH2018PTC312958. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹0.10 M.
Its leadership includes Anil Kedarnath Yadav (Director), Gyan Anil Yadav (Director). Past directors included Anil Yadav, Gyan Anil Yadav. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 159 B Wing Orchard, Road Mall, Goregaon East, Royal Palms Survey No. 169 Aarey, Milk Cly Mumbai, Maharashtra, 400065.
U24111MH2018PTC312958
312958
21 August 2018
₹0.40 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Revigro Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kedarnath Yadav | Director | 21 Aug 2018 | Current |
| Gyan Anil Yadav | Director | 02 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Revigro Pharmaceutical Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.19% increase. The company also saw a substantial improvement in profitability, with a 343.6% increase in profit. The company's net worth Soared by an impressive increase of 35.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Revigro Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Revigro Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Revigro Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revigro Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Revigro Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Revigro Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Gyan Anil Yadav was appointed as a Director was appointed as a Director on 02 Feb 2024 & has been associated with this company since 1 year 10 months . was completed.
The activity Anil Kedarnath Yadav was appointed as a Director was appointed as a Director on 21 Aug 2018 & has been associated with this company since 7 years 4 months . was completed.
Progress on Revigro Pharmaceutical Private Limited was registered on 21 Aug 2018 with Roc Mumbai & aged 7 years 4 months as per MCA records. was documented.
The CIN of Revigro Pharmaceutical Private Limited is U24111MH2018PTC312958.
Revigro Pharmaceutical Private Limited is headquartered at 159 B Wing Orchard, Road Mall, Goregaon East, Royal Palms Survey No. 169 Aarey, Milk Cly Mumbai, Maharashtra, 400065.
Revigro Pharmaceutical Private Limited was incorporated on 21 August 2018.
The current directors of Revigro Pharmaceutical Private Limited are
The primary industry of Revigro Pharmaceutical Private Limited is Trade.
Revigro Pharmaceutical Private Limited is unlisted.
The authorized capital of Revigro Pharmaceutical Private Limited is ₹0.40 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX